EW vs VBIX · P/E 47, rev $1.39B vs rev $26.9M
Edwards Lifesciences Corp (EW) versus Viewbix Inc. Common Stock (VBIX) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Viewbix Inc. Common Stock (VBIX) is a internet content & information company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported VBIX revenue for 2024-12-31 was $26.9M. Net income was -$14.1M. Revenue was down 66.2% from 2023-12-31 to 2024-12-31. VBIX currently screens at market cap $48.5M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. VBIX currently screens at market cap $48.5M.
Not investment advice. Open the EW and VBIX stock pages for the full models.
Not investment advice.